Comparative assessment of antihypertensive and antiischemic efficcacy of eprosartan (Teveten) and betaloc-zoc in arterial hypertension associated with ischemic disfuntion of the heart

We examined 33 patients aged 41-76 years having stable class II-III effort angina associated with arterial hypertension of 1-2 degrees and left ventricular diastolic dysfunction. Prevailing antianginal effect of betaloc-zoc above eprosartan was revealed: reduction of frequency of angina by 35,1%, need in nitroglycerin pills by 46,8%, increased threshold capacity of loading by 19,8%, improvement of quality of life by 20,7% in betaloc-zoc patients. Hypotensive action of eprosartan was comparable with the effect of betaloc-zoc. Decreased diastolic dysfunction was noted in both groups. Eprosartan was well tolerated.